Stroke AHA/ASA/X
Jun 12, 2025, 06:59
DOACs vs. Warfarin in Cerebral Venous Thrombosis: ACTION-CVT Study Shows Safer Profile Without Compromising Efficacy
Stroke AHA/ASA shared on X:
“STROKE In the Multicenter International Study ACTION CVT, patients with Cerebral Venous Thrombosis treated with DOACs had similar rate of thrombosis recurrence and recanalization rates, but lower risk of major hemorrhages, when compared to warfarin (1/3)”
Title: Low incidence of thromboembolism with Fiix-monitored warfarin compared to conventional warfarin and DOACs in patients with AF.
Authors: Arnar B. Ingason, Brynja R. Gudmundsdottir, Ragnar Palsson, Johann P. Hreinsson, Sigrun H. Lund, Loic R. Letertre, Edward Rumba, Arnar S. Agustsson, Einar S. Bjornsson, Pall T. Onundarson.
Read more about it in Blood Vessels, Thrombosis & Hemostasis (2025).
Discover more in Hemostasis Today.
Arnar B. Ingason
Arnar S. Agustsson
ASH
Blood Vessels
Brynja R. Gudmundsdottir
BVTH 2025
Cerebral Venous Thrombosis
DOACs
DOACs vs. Warfarin
Edward Rumba
Einar S. Bjornsson
Johann P. Hreinsson
Loic R. Letertre
Pall T. Onundarson.
Ragnar Palsson
Sigrun H. Lund
Study ACTION CVT
Thrombosis & Hemostasis
Thrombosis and Haemostasis
-
May 6, 2026, 10:55Hugo Antonio Romo Rubio: A New Paradigm in Treatment for Hemophilia A from FRONTIERS2 Phase 3 Study
-
May 6, 2026, 10:40Ifeanyichukwu Ifechidere: Why INR Can Be Dangerously Misleading
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Connecting with so Many Families and Advocates at HFA 2026
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?
-
May 6, 2026, 02:23Khaled Musallam: When the Worlds of Thalassemia and Hemophilia Converge
-
May 6, 2026, 02:12Caitlin Raymond: How STOP-BABESIOSIS Just Rewrote 40 Years of Practice
-
May 5, 2026, 16:28Nikolay Novitski: A New Era in Cardiovascular Prevention
-
May 5, 2026, 16:23Satyam Arora: Best Abstract Award in Pediatric Apheresis at ASFA 2026 Congress